At the end of this activity, participants should be able to summarize both the relevant neuroanatomy and the latest neuroscientific explanations of substance use disorder (SUD) pathophysiology as well as correctly interpret SUD symptomology in light of this research; and describe the evidence supporting SUD as a brain disease but also understand the limitations of the “disease model” in trying to frame addiction as a volitional disorder. Participants should also be able to explain how diverse models of professional treatment and community-based support can suggest strategies to restore volitional capacity and functionality in people recovering from SUDs; and recall the latest research on addiction to suggest behavior change and interventions that can impact the different areas of the brain involved in SUDs and the specific pathophysiologic deficits they contribute to the process of addiction.
Kevin T. McCauley, M.D., director of program services, New Roads Treatment Centers, Salt Lake City, Utah
Continuing Education Credit
Michigan Pharmacists Association (MPA) is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. Universal Activity #0112-0000-16-901-H04-T; 1.25 contact hours; Initial Release Date: 6/3/2016; Expiration Date: 6/3/2019
For questions regarding continuing education, please contact MPA Director of Continuing Education Mary Farrington at (517) 377-0234.